Lilah Khoja

Ms. Lilah Khoja

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2019 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
KKader Konuk
Kader Konuk
LBLatifa Bazzi
Latifa Bazzi
LKLilah Khoja
Lilah Khoja
FHFatima Hassan
Fatima Hassan
CLCarlos Mendes de Leon
Carlos Mendes de Leon

1 December 2019 in Gynecologic Oncology
Verified
Journal Article
Closed access
AAAliya Alimujiang
Aliya Alimujiang
LKLilah Khoja
Lilah Khoja
AWAshley Wiensch
Ashley Wiensch
MPMalcolm C. Pike
Malcolm C. Pike
PWPenelope M. Webb
Penelope M. Webb
Celeste Leigh PearceCeleste Leigh Pearce
Celeste Leigh Pearce

7 August 2020 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
ALAlice Lee
Alice Lee
SRStacey Rosenzweig
Stacey Rosenzweig
AWAshley Wiensch
Ashley Wiensch
TGthe Australian Ovarian Cancer Study Group
the Australian Ovarian Cancer Study Group
SRSusan Ramus
Susan Ramus
Celeste Leigh PearceCeleste Leigh Pearce
Celeste Leigh Pearce
Parity is associated with decreased risk of invasive ovarian cancer; however, the relationship between incomplete pregnancies and invasive ovarian cancer risk is unclear. This relationship was examined using 15 case-control studies from the Ovarian Cancer Association Consortium (OCAC). Histotype-specific associations, which have not been examined previously with large sample sizes, were also evaluated. A pooled analysis of 10 470 invasive epithelial ovarian cancer cases and 16 942 controls was conducted. Odds ratios (ORs) and 95% confidence intervals (CIs) for the association between incomplete pregnancies and invasive epithelial ovarian cancer were estimated using logistic regression. All models were conditioned on OCAC study, race and ethnicity, age, and education level and adjusted for number of complete pregnancies, oral contraceptive use, and history of breastfeeding. The same approach was used for histotype-specific analyses. Ever having an incomplete pregnancy was associated with a 16% reduction in ovarian cancer risk (OR = 0.84, 95% CI = 0.79 to 0.89). There was a trend of decreasing risk with increasing number of incomplete pregnancies (2-sided Ptrend < .001). An inverse association was observed for all major histotypes; it was strongest for clear cell ovarian cancer. Incomplete pregnancies are associated with a reduced risk of invasive epithelial ovarian cancer. Pregnancy, including incomplete pregnancy, was associated with a greater reduction in risk of clear cell ovarian cancer, but the result was broadly consistent across histotypes. Future work should focus on understanding the mechanisms underlying this reduced risk.

24 April 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
LKLilah Khoja
Lilah Khoja
YWYuting Wang
Yuting Wang
SHSyed Emdadul Haque
Syed Emdadul Haque
HAHabibul Ahsan
Habibul Ahsan
TITariqul Islam
Tariqul Islam
Celeste Leigh PearceCeleste Leigh Pearce
Celeste Leigh Pearce
Human Papillomavirus (HPV) self-sampling has been implemented successfully as an alternative to traditional forms of cervical cancer screening in low-resource settings. Through Bangladesh’s current national cervical cancer screening program, only about 10% of the at-risk population is reached. Thus, Bangladesh is an ideal setting to consider HPV self-sampling to improve cervical cancer prevention efforts. However, the feasibility and acceptability of HPV self-sampling has not been evaluated in Bangladesh. We aimed to understand levels of HPV and cervical cancer knowledge and to evaluate the feasibility and acceptability of HPV self-sampling for cervical cancer screening in a semi-urban Bangladeshi community. Participants were recruited from a local clinic; 164 women completed a cross-sectional questionnaire about attitudes towards screening, and cervical cancer and HPV risk factor knowledge, and provided self-collected cervical samples for high-risk HPV testing. Of the participants, 4.3% tested positive for high-risk HPV and were referred for appropriate follow-up care. Nearly all participants had heard of cervical cancer, though specific knowledge was quite low. Self-sampling for high-risk HPV testing had high rates of acceptability, high rates of convenience, and very little discomfort and embarrassment reported in this study population, making implementing HPV self-sampling as a form of cervical cancer screening in Bangladesh appear feasible.

12 November 2021 in Gynecologic Oncology
Verified
Journal Article
Closed access
LKLilah Khoja
Lilah Khoja
RWRachel Palmieri Weber
Rachel Palmieri Weber
PWPenelope M Webb
Penelope M Webb
SJSusan J. Jordan
Susan J. Jordan
AMAruna Muthukumar
Aruna Muthukumar
ALAlice Lee
Alice Lee

17 November 2021 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
KBKatharine K. Brieger
Katharine K. Brieger
MPMinh Tung Phung
Minh Tung Phung
BMBhramar Mukherjee
Bhramar Mukherjee
KBKelly Bakulski
Kelly Bakulski
HAHoda Anton-Culver
Hoda Anton-Culver
Celeste Leigh PearceCeleste Leigh Pearce
Celeste Leigh Pearce
Background: There is suggestive evidence that inflammation is related to ovarian cancer survival. However, more research is needed to identify inflammation-related factors that are associated with ovarian cancer survival and to determine their combined effects. Methods: This analysis used pooled data on 8,147 women with invasive epithelial ovarian cancer from the Ovarian Cancer Association Consortium. The prediagnosis inflammation-related exposures of interest included alcohol use; aspirin use; other nonsteroidal anti-inflammatory drug use; body mass index; environmental tobacco smoke exposure; history of pelvic inflammatory disease, polycystic ovarian syndrome, and endometriosis; menopausal hormone therapy use; physical inactivity; smoking status; and talc use. Using Cox proportional hazards models, the relationship between each exposure and survival was assessed in 50% of the data. A weighted inflammation-related risk score (IRRS) was developed, and its association with survival was assessed using Cox proportional hazards models in the remaining 50% of the data. Results: There was a statistically significant trend of increasing risk of death per quartile of the IRRS [HR = 1.09; 95% confidence interval (CI), 1.03–1.14]. Women in the upper quartile of the IRRS had a 31% higher death rate compared with the lowest quartile (95% CI, 1.11–1.54). Conclusions: A higher prediagnosis IRRS was associated with an increased mortality risk after an ovarian cancer diagnosis. Further investigation is warranted to evaluate whether postdiagnosis exposures are also associated with survival. Impact: Given that pre- and postdiagnosis exposures are often correlated and many are modifiable, our study results can ultimately motivate the development of behavioral recommendations to enhance survival among patients with ovarian cancer.